Vascular Access Devices – Market Insights – Japan

Following the initial impact of the COVID-19 pandemic, the Japanese market for vascular access devices will decline through 2029, limited by strong pricing pressures and continued efforts to control overall health care costs. 

This Medtech 360 Report provides comprehensive data and analysis on the current state of the Japanese vascular access device market across a 10-year period.

The COVID-19 global pandemic will have a dual effect on the vascular access market in the short term.

How will trends change in different vascular access device segments as a consequence of COVID-19? 

What factors contribute to the market changes?

How quickly are procedure volumes expected to recover?

What plans are being executed by manufacturers in response to the pandemic?

Health care cost-containment efforts throughout Japan have placed pressure on the pricing of vascular access devices, leading to reimbursement cuts and price reductions.

Which device segments will face the greatest pricing pressures?

Which segments are continuing to display revenue growth despite these pressures? 

The Japanese market for vascular access devices is dominated by large MNCs; however, smaller, low-cost domestic competitors are maintaining a presence.

Which companies are leading the market and what has contributed to their success?

How are smaller companies competing with large MNCs?

What strategies can companies implement to remain competitive?

The use of image guidance for catheter tip positioning will expand over the forecast period.

How will adoption of these devices impact the use of vascular access devices?